AHS Treatment By Clinical Forms of The Disease, By Diagnosis of the Disease And Prevention Strategies and By Region and Forecast 2025-2033


Posted June 17, 2025 by mrunal_fma

African horse sickness (AHS) is a severe and frequently lethal illness brought on by the African horse sickness virus. This disease is characterized by nine different serotypes; each associated with the virus.

 
According to FutureWise analysis, the market for African Horse Sickness Treatment is estimated to be US$ 0.84 billion in 2023 and is expected to reach US$ 2.98 billion by 2031 at a CAGR of 17.20% over the forecast period of 2025-2033.
African horse sickness (AHS) is a severe and frequently lethal illness brought on by the African horse sickness virus. This disease is characterized by nine different serotypes; each associated with the virus. AHS is not transmitted directly between animals; instead, it spreads through various insect vectors. The primary hosts affected by AHS include horses, mules, donkeys, and zebras. While other animals such as elephants, camels, and dogs can become infected, they typically exhibit few, if any, symptoms—often acquiring the virus through the consumption of infected horse meat. Key insect vectors responsible for the spread of AHS include Culicoides midges, mosquitoes (notably Culex, Anopheles, and Aedes species, including A. aegypti), as well as certain tick species such as Hyalomma and Rhipicephalus.
FutureWise Market Research has published a report that provides an insightful analysis of African Horse Sickness Treatment trends that are affecting the overall market growth.

Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=13510%20&type=requestsample
African Horse Sickness Treatment Segmentation:
By Clinical Forms of The Disease

• Pulmonary Form or “Dunkop”
• Cardiac Form or “Dikkop”
• Mixed Form
• Horse Sickness Fever

By Diagnosis of the Disease And Prevention Strategies

• Diagnosis Tests
o Laboratory Tests for Viral Antigens
o Enzyme-linked Immunosorbent Assays (ELISA)
o Reverse-transcription PCR Assays
• Serological Tests
o Prevention Treatment
o Vaccines
By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in African Horse Sickness Treatment:
• Onderstepoort Biological Products SOC Ltd.
• Boehringer Ingelheim
• Zoetis
• Merial
• Veterinary Serum & Vaccine Research Institute

Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=13510&license=multi


**Objectives of this Study: **
1. To provide a comprehensive analysis of the African Horse Sickness Treatment By Clinical Forms of The Disease, By Diagnosis of the Disease And Prevention Strategies and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: [email protected]

FutureWise Research
Contact Person: Vinay Thaploo.
Email: [email protected]
Contact Number: Asia: +91 8605575209 | UK: +44 0113 519 7222
Website: www.futurewiseresearch.com
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By FutureWise Research
Country United States
Categories Health
Tags african horse sickness treatment size , african horse sickness treatment share , african horse sickness treatment trends
Last Updated June 17, 2025